Eli Lilly's Alzheimer's Drug Donanemab Is Being Considered For FDA Approval—Here's What To Know

ToplineA panel of experts advising the Food and Drug Administration could on Monday recommend Eli Lilly’s experimental Alzheimer’s drug donanemab for FDA approval, a closely watched decision that could pave the way for the drug to become the second of its kind authorized in the U.S..Experts are weighing up donanemab, Eli Lilly's Alzheimer's drug. getty Key FactsThe Peripheral and Central Nervous System Drugs Advisory Committee will meet on Monday to consider whether the benefits of Lilly’s drug outweigh its ...